Harmony Biosciences Holdings Stock Forecast

Outlook: Harmony Biosciences Holdings is assigned short-term Ba3 & long-term B2 estimated rating.
AUC Score : What is AUC Score?
Short-term Tactic1 :
Dominant Strategy :
Time series to forecast n: for Weeks2
ML Model Testing : Modular Neural Network (Market Direction Analysis)
Hypothesis Testing : Spearman Correlation
Surveillance : Major exchange and OTC

1Short-term revised.

2Time series is updated based on short-term trends.


Key Points

HARB's stock is predicted to experience continued growth driven by the increasing adoption of its narcolepsy treatments and potential market expansion for its existing products. However, risks include intensifying competition from new entrants in the sleep disorder market, regulatory hurdles for future drug approvals, and pricing pressures from payers. Furthermore, the company's reliance on a limited pipeline presents a vulnerability should pipeline assets fail to reach commercialization or underperform expectations.

About Harmony Biosciences Holdings

This exclusive content is only available to premium users.
HRMY
This exclusive content is only available to premium users.

ML Model Testing

F(Spearman Correlation)6,7= p a 1 p a 2 p 1 n p j 1 p j 2 p j n p k 1 p k 2 p k n p n 1 p n 2 p n n X R(Modular Neural Network (Market Direction Analysis))3,4,5 X S(n):→ 4 Weeks S = s 1 s 2 s 3

n:Time series to forecast

p:Price signals of Harmony Biosciences Holdings stock

j:Nash equilibria (Neural Network)

k:Dominated move of Harmony Biosciences Holdings stock holders

a:Best response for Harmony Biosciences Holdings target price

 

For further technical information as per how our model work we invite you to visit the article below: 

How do KappaSignal algorithms actually work?

Harmony Biosciences Holdings Stock Forecast (Buy or Sell) Strategic Interaction Table

Strategic Interaction Table Legend:

X axis: *Likelihood% (The higher the percentage value, the more likely the event will occur.)

Y axis: *Potential Impact% (The higher the percentage value, the more likely the price will deviate.)

Z axis (Grey to Black): *Technical Analysis%

This exclusive content is only available to premium users.
Rating Short-Term Long-Term Senior
OutlookBa3B2
Income StatementCB2
Balance SheetBaa2B3
Leverage RatiosBaa2Caa2
Cash FlowCaa2Caa2
Rates of Return and ProfitabilityBaa2Ba1

*Financial analysis is the process of evaluating a company's financial performance and position by neural network. It involves reviewing the company's financial statements, including the balance sheet, income statement, and cash flow statement, as well as other financial reports and documents.
How does neural network examine financial reports and understand financial state of the company?

References

  1. S. Bhatnagar and K. Lakshmanan. An online actor-critic algorithm with function approximation for con- strained Markov decision processes. Journal of Optimization Theory and Applications, 153(3):688–708, 2012.
  2. R. Sutton and A. Barto. Reinforcement Learning. The MIT Press, 1998
  3. Hastie T, Tibshirani R, Friedman J. 2009. The Elements of Statistical Learning. Berlin: Springer
  4. J. Z. Leibo, V. Zambaldi, M. Lanctot, J. Marecki, and T. Graepel. Multi-agent Reinforcement Learning in Sequential Social Dilemmas. In Proceedings of the 16th International Conference on Autonomous Agents and Multiagent Systems (AAMAS 2017), Sao Paulo, Brazil, 2017
  5. P. Marbach. Simulated-Based Methods for Markov Decision Processes. PhD thesis, Massachusetts Institute of Technology, 1998
  6. S. Proper and K. Tumer. Modeling difference rewards for multiagent learning (extended abstract). In Proceedings of the Eleventh International Joint Conference on Autonomous Agents and Multiagent Systems, Valencia, Spain, June 2012
  7. Y. Le Tallec. Robust, risk-sensitive, and data-driven control of Markov decision processes. PhD thesis, Massachusetts Institute of Technology, 2007.

This project is licensed under the license; additional terms may apply.